LSI Industries (LYTS) Form 5 shows deferred‑compensation share allocations
Rhea-AI Filing Summary
LSI Industries Inc. (LYTS) filing reports James E. Galeese, Executive VP and CFO, on the annual Form 5 covering the fiscal year ended 06/30/2025. The statement shows a disposition entry of 134,788 common shares and a series of periodic small acquisitions recorded between 07/12/2024 and 06/27/2025, with individual purchases generally in the 180–268 share range.
The filing notes the shares are held in the company’s Non‑Qualified Deferred Compensation Plan and reports a year‑end beneficial ownership balance of 74,333 common shares. The form is signed by an attorney‑in‑fact on behalf of Mr. Galeese.
Positive
- None.
Negative
- None.
Insights
Routine insider reporting: periodic deferred‑compensation allocations led to modest net holdings of 74,333 shares; no material event disclosed.
The Form 5 documents scheduled, small acquisitions across fiscal 2025 under the issuer’s Non‑Qualified Deferred Compensation Plan, and a prior disposition entry of 134,788 shares. Transactions are incremental and appear administrative rather than strategic; the filing does not present earnings, financing, or governance changes that would materially alter investor valuation based on the information provided.
Disclosure is procedural and compliant: annual reporting of beneficial ownership with attorney‑in‑fact signature; no governance concerns stated.
The report identifies the reporting person as Executive VP and CFO and explains the indirect ownership vehicle as the company’s Non‑Qualified Deferred Compensation Plan. The filing reflects regular plan allocations and includes an attorney‑in‑fact signature, indicating representative execution rather than a substantive governance action.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Common Stock | 234 | $17.08 | $4K |
| Grant/Award | Common Stock | 248 | $16.11 | $4K |
| Grant/Award | Common Stock | 244 | $16.27 | $4K |
| Grant/Award | Common Stock | 246 | $16.26 | $4K |
| Grant/Award | Common Stock | 250 | $15.95 | $4K |
| Grant/Award | Common Stock | 253 | $15.80 | $4K |
| Grant/Award | Common Stock | 259 | $15.39 | $4K |
| Grant/Award | Common Stock | 229 | $17.33 | $4K |
| Grant/Award | Common Stock | 228 | $17.53 | $4K |
| Grant/Award | Common Stock | 207 | $19.26 | $4K |
| Grant/Award | Common Stock | 189 | $21.03 | $4K |
| Grant/Award | Common Stock | 180 | $22.08 | $4K |
| Grant/Award | Common Stock | 218 | $18.26 | $4K |
| Grant/Award | Common Stock | 205 | $19.43 | $4K |
| Grant/Award | Common Stock | 198 | $20.12 | $4K |
| Grant/Award | Common Stock | 195 | $20.44 | $4K |
| Grant/Award | Common Stock | 199 | $20.07 | $4K |
| Grant/Award | Common Stock | 241 | $16.49 | $4K |
| Grant/Award | Common Stock | 238 | $16.72 | $4K |
| Grant/Award | Common Stock | 242 | $16.40 | $4K |
| Grant/Award | Common Stock | 248 | $16.04 | $4K |
| Grant/Award | Common Stock | 252 | $15.33 | $4K |
| Grant/Award | Common Stock | 252 | $15.39 | $4K |
| Grant/Award | Common Stock | 268 | $14.38 | $4K |
| Grant/Award | Common Stock | 240 | $16.10 | $4K |
| Grant/Award | Common Stock | 254 | $15.16 | $4K |
Footnotes (1)
- [object Object]